Literature DB >> 29314041

Surgical morbidity in retroperitoneal sarcoma resection.

Andrea J MacNeill1,2, Marco Fiore3.   

Abstract

Resection of retroperitoneal sarcoma (RPS) typically involves multivisceral resection. The morbidity of RPS resection has decreased over time despite widespread adoption of radical resection. Certain patterns of resection are associated with higher complication rates and elderly patients are at increased risk of morbidity. Administration of preoperative radiotherapy does not increase morbidity, but intraoperative and brachytherapy techniques are associated with heightened toxicities. Long-term functional outcomes and quality of life scores after RPS resection are acceptable.
© 2018 The Authors. Journal of Surgical Oncology Published by Wiley Periodicals, Inc.

Entities:  

Keywords:  adverse events; mortality; quality of life; radical resection; retroperitoneal sarcoma

Mesh:

Year:  2018        PMID: 29314041     DOI: 10.1002/jso.24902

Source DB:  PubMed          Journal:  J Surg Oncol        ISSN: 0022-4790            Impact factor:   3.454


  5 in total

1.  Retroperitoneal Sarcomas: Prognostic Factors and Outcomes of a Series of Patients Treated at a Single Institution.

Authors:  Shraddha Patkar; Abhay K Kattepur; Rajesh Shinde; Mahesh Goel
Journal:  Indian J Surg Oncol       Date:  2020-01-15

Review 2.  Retroperitoneal Sarcomas: a Current Review on Management.

Authors:  Shraddha Patkar; Abhay K Kattepur; Nehal Khanna; Jyoti Bajpai
Journal:  Indian J Surg Oncol       Date:  2022-02-21

3.  A Prospective Observational Study of Multivisceral Resection for Retroperitoneal Sarcoma: Clinical and Patient-Reported Outcomes 1 Year After Surgery.

Authors:  Marco Fiore; Cinzia Brunelli; Rosalba Miceli; Michele Manara; Susanna Lenna; Nicolò N Rampello; Dario Callegaro; Chiara Colombo; Stefano Radaelli; Sandro Pasquali; Augusto T Caraceni; Alessandro Gronchi
Journal:  Ann Surg Oncol       Date:  2020-11-11       Impact factor: 5.344

4.  Retroperitoneal soft-tissue sarcomas: Radiotherapy experience from a tertiary cancer center and review of current evidence.

Authors:  A Montero; M Nuñez; O Hernando; E Vicente; R Ciervide; D Zucca; E Sanchez; M López; Y Quijano; M Garcia-Aranda; R Alonso; J Valero; X Chen; B Alvarez; P Fernandez-Leton; C Rubio
Journal:  Rep Pract Oncol Radiother       Date:  2020-06-09

Review 5.  Surgical Principles of Primary Retroperitoneal Sarcoma in the Era of Personalized Treatment: A Review of the Frontline Extended Surgery.

Authors:  Paula Munoz; Pedro Bretcha-Boix; Vicente Artigas; José Manuel Asencio
Journal:  Cancers (Basel)       Date:  2022-08-24       Impact factor: 6.575

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.